» Articles » PMID: 17785802

Characterization of Early Stages of Human B Cell Development by Gene Expression Profiling

Overview
Journal J Immunol
Date 2007 Sep 6
PMID 17785802
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

We have characterized several stages of normal human B cell development in adult bone marrow by gene expression profiling of hemopoietic stem cells, early B (E-B), pro-B, pre-B, and immature B cells, using RNA amplification and Lymphochip cDNA microarrays (n = 6). Hierarchical clustering of 758 differentially expressed genes clearly separated the five populations. We used gene sets to investigate the functional assignment of the differentially expressed genes. Genes involved in VDJ recombination as well as B lineage-associated transcription factors (TCF3 (E2A), EBF, BCL11A, and PAX5) were turned on in E-B cells, before acquisition of CD19. Several transcription factors with unknown roles in B lymphoid cells demonstrated interesting expression patterns, including ZCCHC7 and ZHX2. Compared with hemopoietic stem cells and pro-B cells, E-B cells had increased expression of 18 genes, and these included IGJ, IL1RAP, BCL2, and CD62L. In addition, E-B cells expressed T/NK lineage and myeloid-associated genes including CD2, NOTCH1, CD99, PECAM1, TNFSF13B, and MPO. Expression of key genes was confirmed at the protein level by FACS analysis. Several of these Ags were heterogeneously expressed, providing a basis for further subdivision of E-B cells. Altogether, these results provide new information regarding expression of genes in early stages of human B cell development.

Citing Articles

Characterization of unique B-cell populations in the circulation of people living with HIV prior to non-Hodgkin lymphoma diagnosis.

Martinez L, Comin-Anduix B, Guemes-Aragon M, Ibarrondo J, Detels R, Mimiaga M Front Immunol. 2024; 15():1441994.

PMID: 39324141 PMC: 11422120. DOI: 10.3389/fimmu.2024.1441994.


Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia.

Huang X, Li Y, Zhang J, Yan L, Zhao H, Ding L Cancer Cell. 2024; 42(4):552-567.e6.

PMID: 38593781 PMC: 11008188. DOI: 10.1016/j.ccell.2024.03.003.


The RNA tether model for human chromosomal translocation fragile zones.

Liu D, Hsieh C, Lieber M Trends Biochem Sci. 2024; 49(5):391-400.

PMID: 38490833 PMC: 11069435. DOI: 10.1016/j.tibs.2024.02.003.


Transcriptomic classes of BCR-ABL1 lymphoblastic leukemia.

Kim J, Chan-Seng-Yue M, Ge S, Zeng A, Ng K, Gan O Nat Genet. 2023; 55(7):1186-1197.

PMID: 37337105 PMC: 10335939. DOI: 10.1038/s41588-023-01429-4.


Zhx2 maintains islet β-cell mass and function by transcriptionally regulating Pax6.

Ding L, Zhang Y, Wang Y, Wang Y, Tong Z, Li P iScience. 2023; 26(6):106871.

PMID: 37275527 PMC: 10232729. DOI: 10.1016/j.isci.2023.106871.